December 11, 2009 (FinancialWire) — Skinvisible, Inc. (OTCBB: SKVI) and Alto Pharmaceuticals have entered into a license agreement for DermSafe(R), Skinvisible’s antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus.

Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial / professional use marketing rights for DermSafe in Canada. Skinvisible will also receive a royalty from product sales.

DermSafe claims its product does not contain alcohol and therefore is non-drying to the skin, and that schools, penitentiaries and other groups with safety concerns have discontinued the use of alcohol-based hand sanitizers.

The active ingredient in DermSafe is chlorhexidine gluconate, an ingredient approved by Health Canada under the Human Use Antiseptic Drugs Monograph. This ingredient has been safely used in hospitals worldwide as a pre-surgical scrub as well as in dental applications.

This license agreement is the second DermSafe agreement signed by Skinvisible. The DermSafe licensee, Mayquest Pharmaceuticals, based in Singapore, recently received approval to import DermSafe to Singapore and will commence commercial / professional sales in January 2010. Mayquest Pharmaceuticals has licensed the rights for DermSafe for five countries in Southeast Asia.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.